279 related articles for article (PubMed ID: 12015077)
41. Expression of CD20 on acute lymphoblastic leukemia cells in children.
Pituch-Noworolska A; Hajto B; Mazur B; Sońta-Jakimczyk D; Balwierz W; Janota-Krawczyk E; Kowalska H; Malinowska I; Modzelewska M; Wasik M
Neoplasma; 2001; 48(3):182-7. PubMed ID: 11583286
[TBL] [Abstract][Full Text] [Related]
42. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients.
Unal S; Cetin M; Tuncer AM; Gümrük F; Yetgin S
Turk J Pediatr; 2008; 50(6):533-6. PubMed ID: 19227415
[TBL] [Abstract][Full Text] [Related]
43. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
[TBL] [Abstract][Full Text] [Related]
44. [Characteristic analysis of acute leukemia immunophenotyping in 180 cases by flow cytometry].
Yao ZJ; Liao L; Dang YH; Zhang J; Tian Y; Feng K; Qi CY; Wang JF; Chen H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):83-5. PubMed ID: 14989776
[TBL] [Abstract][Full Text] [Related]
45. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
46. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
47. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
Hanson CA; Ross CW; Schnitzer B
Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
[TBL] [Abstract][Full Text] [Related]
48. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.
Chen W; Karandikar NJ; McKenna RW; Kroft SH
Am J Clin Pathol; 2007 Jan; 127(1):39-46. PubMed ID: 17145625
[TBL] [Abstract][Full Text] [Related]
49. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
50. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
51. Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates and peripheral blood of healthy adults.
Höffkes H; Schmidtke G; Schmücker U; Uppenkamp M; Brittinger G
Eur J Med Res; 1995 Oct; 1(1):2-8. PubMed ID: 9392686
[TBL] [Abstract][Full Text] [Related]
52. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
Zelezníková T; Babusíková O
Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
[TBL] [Abstract][Full Text] [Related]
53. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama J; Orfao A;
Cytometry B Clin Cytom; 2006 Jan; 70(1):1-9. PubMed ID: 16278833
[TBL] [Abstract][Full Text] [Related]
54. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
55. Analysis of clinical flow cytometric immunophenotyping data by clustering on statistical manifolds: treating flow cytometry data as high-dimensional objects.
Finn WG; Carter KM; Raich R; Stoolman LM; Hero AO
Cytometry B Clin Cytom; 2009 Jan; 76(1):1-7. PubMed ID: 18642311
[TBL] [Abstract][Full Text] [Related]
56. The immunophenotype of pre-TALL/LBL revisited.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Tillman BF; Beason KL; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):162-5. PubMed ID: 16908018
[TBL] [Abstract][Full Text] [Related]
57. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
[TBL] [Abstract][Full Text] [Related]
58. [Use of flow cytometry in the diagnosis of acute leukemias in childhood].
Starý J; Sokol L; Hausner P; Hrodek O; Sedmihorská J; Volejníková J; Vlachynský M
Cas Lek Cesk; 1992 Jun; 131(12):364-7. PubMed ID: 1504986
[TBL] [Abstract][Full Text] [Related]
59. [Chromosome t (4; 11) acute lymphoblastic leukemia: an analysis of 10 cases].
Guo Y; Xue Y; Xie X; Lu D; Geng M
Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):71-3. PubMed ID: 11876961
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
